James Buchanan

James Buchanan

University of Oxford

H-index: 21

Europe-United Kingdom

About James Buchanan

James Buchanan, With an exceptional h-index of 21 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Health Economics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

QALYs and Rare Diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia

Economic Evaluation in Genomic and Precision Medicine

Retrospective file review shows limited genetic services fail most patients–an argument for the implementation of exome sequencing as a first-tier test in resource-constrained …

Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients

Using “big data” for economic evaluations in genomics

Resource allocation in genetic and genomic medicine

James Buchanan Information

University

Position

Senior Researcher

Citations(all)

2391

Citations(since 2020)

2056

Cited By

926

hIndex(all)

21

hIndex(since 2020)

19

i10Index(all)

34

i10Index(since 2020)

32

Email

University Profile Page

Google Scholar

James Buchanan Skills & Research Interests

Health Economics

Top articles of James Buchanan

Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure

Genetics in Medicine

2024/3/1

Paving the path for implementation of clinical genomic sequencing globally-Are we ready?

Health Affairs Scholar

2024/4/29

James Buchanan
James Buchanan

H-Index: 13

Jeroen P Jansen
Jeroen P Jansen

H-Index: 30

QALYs and Rare Diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia

Health and Quality of Life Outcomes

2023/12/2

Economic Evaluation in Genomic and Precision Medicine

2023/4/19

James Buchanan
James Buchanan

H-Index: 13

Retrospective file review shows limited genetic services fail most patients–an argument for the implementation of exome sequencing as a first-tier test in resource-constrained …

Orphanet Journal of Rare Diseases

2023/4/12

James Buchanan
James Buchanan

H-Index: 13

Amanda Krause
Amanda Krause

H-Index: 21

Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients

Academy of Management Proceedings

2023

James Buchanan
James Buchanan

H-Index: 13

Using “big data” for economic evaluations in genomics

2023/1/1

James Buchanan
James Buchanan

H-Index: 13

Christopher Mccabe
Christopher Mccabe

H-Index: 28

Resource allocation in genetic and genomic medicine

Journal of Community Genetics

2022/10

Defining a Core Data Set for the Economic Evaluation of Precision Oncology

2022/8/1

Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options

2022/7

James Buchanan
James Buchanan

H-Index: 13

Apostolos Tsiachristas
Apostolos Tsiachristas

H-Index: 21

Factors that impact on women's decision‐making around prenatal genomic tests: An international discrete choice survey

2022/6

Eliciting risk preferences that predict risky health behavior: A comparison of two approaches

Health economics

2022/5

James Buchanan
James Buchanan

H-Index: 13

Women's preferences for receiving uncertain results from prenatal genomic testing: An international discrete choice experiment

2022/4/1

Assessing women’s preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a …

2022/1/28

What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK

PharmacoEconomics

2021/12

James Buchanan
James Buchanan

H-Index: 13

Sian Rees
Sian Rees

H-Index: 16

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care—Preliminary Report

New England Journal of Medicine

2021/11/11

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

European Journal of Human Genetics

2021/10

James Buchanan
James Buchanan

H-Index: 13

Mark Harrison
Mark Harrison

H-Index: 25

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: A choice experiment

PLoS medicine

2021/8/30

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam

Open Forum Infectious Diseases

2021/7

Preferences for medical consultations from online providers: evidence from a discrete choice experiment in the United Kingdom

Applied health economics and health policy

2021/7

See List of Professors in James Buchanan University(University of Oxford)

Co-Authors

academic-engine